Literature DB >> 11281988

Cyclic AMP-dependent protein kinase in subtypes of major depression and normal volunteers.

Richard C. Shelton1, D.Hal Manier, Chad S. Peterson, Truitt C. Ellis, Fridolin Sulser.   

Abstract

We have shown a reduction in beta adrenoceptor-linked, cyclic AMP-dependent protein kinase [protein kinase A (PKA)] activity in fibroblasts of patients with major depression with melancholic features relative to normal volunteers. We evaluated a group of 35 patients with major depression subtyped by DSM-IV criteria as melancholic, atypical, and those not meeting either subtype designation ('non-subtyped') and 21 normal volunteers to ascertain whether or not the PKA activity abnormality was specific to melancholia. The melancholics showed marked reduction in cyclic AMP-stimulated PKA activity relative to normal volunteers. Although the atypicals were statistically significantly lower, almost all fell into the range for the normals. The non-subtyped group fell between the atypicals and the melancholics. Basal activity was significantly lower in atypical and melancholic groups. The data suggest that reduced PKA activity is consistently found in melancholic major depression and may not be seen with other depressive subtypes.

Entities:  

Year:  1999        PMID: 11281988     DOI: 10.1017/S1461145799001509

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  11 in total

Review 1.  Human dermal fibroblasts in psychiatry research.

Authors:  S Kálmán; K A Garbett; Z Janka; K Mirnics
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

2.  Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha.

Authors:  Thaddeus W W Pace; Fang Hu; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2011-07-21       Impact factor: 7.217

Review 3.  Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression.

Authors:  Richard C Shelton; Andrew H Miller
Journal:  Prog Neurobiol       Date:  2010-04-22       Impact factor: 11.685

Review 4.  Future antidepressants: what is in the pipeline and what is missing?

Authors:  Fokko J Bosker; Ben H C Westerink; Thomas I F H Cremers; Marjolein Gerrits; Marieke G C van der Hart; Sjoukje D Kuipers; Gieta van der Pompe; Gert J ter Horst; Johan A den Boer; Jakob Korf
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.

Authors:  Richard C Shelton; D Hal Manier; David A Lewis
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-02       Impact factor: 5.176

Review 6.  The molecular neurobiology of depression.

Authors:  Richard C Shelton
Journal:  Psychiatr Clin North Am       Date:  2007-03

Review 7.  The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.

Authors:  F Ferrari; R F Villa
Journal:  Mol Neurobiol       Date:  2016-08-10       Impact factor: 5.590

8.  Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response.

Authors:  Pierre Mesdom; Romain Colle; Elise Lebigot; Séverine Trabado; Eric Deflesselle; Bruno Fève; Laurent Becquemont; Emmanuelle Corruble; Céline Verstuyft
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

9.  Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A.

Authors:  R C Shelton; E Sanders-Bush; D H Manier; D A Lewis
Journal:  Neuroscience       Date:  2008-12-03       Impact factor: 3.708

10.  Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A.

Authors:  Yogesh Dwivedi; Ghanshyam N Pandey
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.